Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Influenza [strain A/H5N1] (quadrivalent) vaccine by Seqirus for Influenzavirus A Infections: Likelihood of Approval
Influenza [strain A/H5N1] (quadrivalent) vaccine is under clinical development by Seqirus and currently in Phase III for Influenzavirus A Infections....
Data Insights
Influenza [strain A/H5N1] (quadrivalent) vaccine by Seqirus for Influenzavirus B Infections: Likelihood of Approval
Influenza [strain A/H5N1] (quadrivalent) vaccine is under clinical development by Seqirus and currently in Phase III for Influenzavirus B Infections....